{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T23:03:19Z","timestamp":1770678199861,"version":"3.49.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2016,10,8]],"date-time":"2016-10-08T00:00:00Z","timestamp":1475884800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1007\/s00296-016-3571-7","type":"journal-article","created":{"date-parts":[[2016,10,8]],"date-time":"2016-10-08T08:15:42Z","timestamp":1475914542000},"page":"1727-1735","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Outcome and prognostic factors in a French cohort of patients with myositis-associated interstitial lung disease"],"prefix":"10.1007","volume":"36","author":[{"given":"Julie","family":"Obert","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olivia","family":"Freynet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hilario","family":"Nunes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierre-Yves","family":"Brillet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makoto","family":"Miyara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robin","family":"Dhote","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dominique","family":"Valeyre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Marc","family":"Naccache","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,10,8]]},"reference":[{"issue":"8","key":"3571_CR1","doi-asserted-by":"publisher","first-page":"403","DOI":"10.105\/NEJM197502202920807","volume":"292","author":"A Bohan","year":"1975","unstructured":"Bohan A, Peter JB (1975) Polymyositis and dermatomyositis (second of two parts). N Engl J Med 292(8):403\u2013407. doi: 10.105\/NEJM197502202920807","journal-title":"N Engl J Med"},{"issue":"7","key":"3571_CR2","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1056\/NEJM197502132920706","volume":"292","author":"A Bohan","year":"1975","unstructured":"Bohan A, Peter JB (1975) Polymyositis and dermatomyositis (first of two parts). N Engl J Med 292(7):344\u2013347. doi: 10.1056\/NEJM197502132920706","journal-title":"N Engl J Med"},{"issue":"4","key":"3571_CR3","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1097\/01.md.0000173991.74008.b0","volume":"84","author":"Y Troyanov","year":"2005","unstructured":"Troyanov Y, Targoff IN, Tremblay JL, Goulet JR, Raymond Y, Senecal JL (2005) Novel classification of idiopathic inflammatory myopathies based on overlap syndrome features and autoantibodies: analysis of 100 French Canadian patients. Medicine 84(4):231\u2013249","journal-title":"Medicine"},{"issue":"9388","key":"3571_CR4","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/S0140-6736(03)14368-1","volume":"362","author":"MC Dalakas","year":"2003","unstructured":"Dalakas MC, Hohlfeld R (2003) Polymyositis and dermatomyositis. Lancet 362(9388):971\u2013982. doi: 10.1016\/S0140-6736(03)14368-1","journal-title":"Lancet"},{"issue":"6","key":"3571_CR5","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1097\/00005792-199111000-00002","volume":"70","author":"LA Love","year":"1991","unstructured":"Love LA, Leff RL, Fraser DD, Targoff IN, Dalakas M, Plotz PH et al (1991) A new approach to the classification of idiopathic inflammatory myopathy: myositis-specific autoantibodies define useful homogeneous patient groups. Medicine 70(6):360\u2013374","journal-title":"Medicine"},{"issue":"282","key":"3571_CR6","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1093\/qjmed\/77.1.1019","volume":"77","author":"C Marguerie","year":"1990","unstructured":"Marguerie C, Bunn CC, Beynon HL, Bernstein RM, Hughes JM, So AK et al (1990) Polymyositis, pulmonary fibrosis and autoantibodies to aminoacyl-tRNA synthetase enzymes. Q J Med 77(282):1019\u20131038","journal-title":"Q J Med"},{"issue":"1","key":"3571_CR7","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/0049-0172(84)90010-6","volume":"14","author":"BF Dickey","year":"1984","unstructured":"Dickey BF, Myers AR (1984) Pulmonary disease in polymyositis\/dermatomyositis. Sem Arthritis Rheum 14(1):60\u201376","journal-title":"Sem Arthritis Rheum"},{"key":"3571_CR8","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/S0025-7125(16)33432-0","volume":"48","author":"NG Hepper","year":"1964","unstructured":"Hepper NG, Ferguson RH, Howard FM Jr (1964) Three types of pulmonary involvement in polymyositis. Med Clin N Am 48:1031\u20131042","journal-title":"Med Clin N Am"},{"issue":"10","key":"3571_CR9","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/j.autrev.2012.01.006","volume":"11","author":"I Marie","year":"2012","unstructured":"Marie I, Josse S, Decaux O, Dominique S, Diot E, Landron C et al (2012) Comparison of long-term outcome between anti-Jo1- and anti-PL7\/PL12 positive patients with antisynthetase syndrome. Autoimmun Rev 11(10):739\u2013745. doi: 10.1016\/j.autrev.2012.01.006","journal-title":"Autoimmun Rev"},{"issue":"7","key":"3571_CR10","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1164\/ajrccm.164.7.2103110","volume":"164","author":"WW Douglas","year":"2001","unstructured":"Douglas WW, Tazelaar HD, Hartman TE, Hartman RP, Decker PA, Schroeder DR et al (2001) Polymyositis-dermatomyositis-associated interstitial lung disease. Am J Respir Crit Care Med 164(7):1182\u20131185. doi: 10.1164\/ajrccm.164.7.2103110","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"3571_CR11","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1378\/chest.123.4.1096","volume":"123","author":"H Arakawa","year":"2003","unstructured":"Arakawa H, Yamada H, Kurihara Y, Nakajima Y, Takeda A, Fukushima Y et al (2003) Nonspecific interstitial pneumonia associated with polymyositis and dermatomyositis: serial high-resolution CT findings and functional correlation. Chest 123(4):1096\u20131103","journal-title":"Chest"},{"issue":"2","key":"3571_CR12","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1183\/09031936.03.00026703","volume":"22","author":"V Cottin","year":"2003","unstructured":"Cottin V, Thivolet-Bejui F, Reynaud-Gaubert M, Cadranel J, Delaval P, Ternamian PJ et al (2003) Interstitial lung disease in amyopathic dermatomyositis, dermatomyositis and polymyositis. Eur Respir J 22(2):245\u2013250","journal-title":"Eur Respir J"},{"issue":"6","key":"3571_CR13","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1016\/j.rmed.2013.02.015","volume":"107","author":"IC Mira-Avendano","year":"2013","unstructured":"Mira-Avendano IC, Parambil JG, Yadav R, Arrossi V, Xu M, Chapman JT et al (2013) A retrospective review of clinical features and treatment outcomes in steroid-resistant interstitial lung disease from polymyositis\/dermatomyositis. Respir Med 107(6):890\u2013896. doi: 10.1016\/j.rmed.2013.02.015","journal-title":"Respir Med"},{"issue":"8","key":"3571_CR14","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1093\/rheumatology\/kep157","volume":"48","author":"M Sem","year":"2009","unstructured":"Sem M, Molberg O, Lund MB, Gran JT (2009) Rituximab treatment of the anti-synthetase syndrome: a retrospective case series. Rheumatology 48(8):968\u2013971. doi: 10.1093\/rheumatology\/kep157","journal-title":"Rheumatology"},{"issue":"7","key":"3571_CR15","doi-asserted-by":"crossref","first-page":"519","DOI":"10.2169\/internalmedicine.36.519","volume":"36","author":"T Shinohara","year":"1997","unstructured":"Shinohara T, Hidaka T, Matsuki Y, Ishizuka T, Takamizawa M, Kawakami M et al (1997) Rapidly progressive interstitial lung disease associated with dermatomyositis responding to intravenous cyclophosphamide pulse therapy. Intern Med 36(7):519\u2013523","journal-title":"Intern Med"},{"issue":"9","key":"3571_CR16","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1093\/rheumatology\/kes102","volume":"51","author":"T Gono","year":"2012","unstructured":"Gono T, Sato S, Kawaguchi Y, Kuwana M, Hanaoka M, Katsumata Y et al (2012) Anti-MDA5 antibody, ferritin and IL-18 are useful for the evaluation of response to treatment in interstitial lung disease with anti-MDA5 antibody-positive dermatomyositis. Rheumatology 51(9):1563\u20131570. doi: 10.1093\/rheumatology\/kes102","journal-title":"Rheumatology"},{"issue":"11","key":"3571_CR17","doi-asserted-by":"publisher","first-page":"3439","DOI":"10.1002\/art.30513","volume":"63","author":"I Marie","year":"2011","unstructured":"Marie I, Hatron PY, Dominique S, Cherin P, Mouthon L, Menard JF (2011) Short-term and long-term outcomes of interstitial lung disease in polymyositis and dermatomyositis: a series of 107 patients. Arthritis Rheum 63(11):3439\u20133447. doi: 10.1002\/art.30513","journal-title":"Arthritis Rheum"},{"issue":"5","key":"3571_CR18","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1007\/s00408-016-9896","volume":"194","author":"C Johnson","year":"2016","unstructured":"Johnson C, Pinal-Fernandez I, Parikh R, Paik J, Albayda J, Mammen AL, Christopher-Stine L, Danoff S (2016) Assessment of mortality in autoimmune myositis with and without associated interstitial lung disease. Lung 194(5):733\u2013737. doi: 10.1007\/s00408-016-9896","journal-title":"Lung"},{"issue":"1","key":"3571_CR19","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1136\/thx.2006.069237","volume":"63","author":"I Tillie-Leblond","year":"2008","unstructured":"Tillie-Leblond I, Wislez M, Valeyre D, Crestani B, Rabbat A, Israel-Biet D et al (2008) Interstitial lung disease and anti-Jo-1 antibodies: difference between acute and gradual onset. Thorax 63(1):53\u201359. doi: 10.1136\/thx.2006.069237","journal-title":"Thorax"},{"issue":"6","key":"3571_CR20","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1164\/rccm.2009-040GL","volume":"183","author":"G Raghu","year":"2011","unstructured":"Raghu G, Collard HR, Egan JJ, Martinez FJ, Behr J, Brown KK et al (2011) An official ATS\/ERS\/JRS\/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med 183(6):788\u2013824. doi: 10.1164\/rccm.2009-040GL","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"3571_CR21","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1183\/09031936.00156312","volume":"42","author":"B Hervier","year":"2013","unstructured":"Hervier B, Meyer A, Dieval C, Uzunhan Y, Devilliers H, Launay D et al (2013) Pulmonary hypertension in antisynthetase syndrome: prevalence, aetiology and survival. Eur Respir J 42(5):1271\u20131282. doi: 10.1183\/09031936.00156312","journal-title":"Eur Respir J"},{"issue":"6","key":"3571_CR22","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1164\/rccm.201308-1483ST","volume":"188","author":"WD Travis","year":"2013","unstructured":"Travis WD, Costabel U, Hansell DM, King TE Jr, Lynch DA, Nicholson AG et al (2013) An official American Thoracic Society\/European Respiratory Society statement: update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med 188(6):733\u2013748. doi: 10.1164\/rccm.201308-1483ST","journal-title":"Am J Respir Crit Care Med"},{"key":"3571_CR23","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1111\/his.12415","volume":"65","author":"M Kambouchner","year":"2014","unstructured":"Kambouchner M, Levy P, Nicholson AG, Schubel K, Magois E, Feuillet S et al (2014) Prognostic relevance of histological variants in nonspecific interstitial pneumonia. Histopathology 65:549\u2013560. doi: 10.1111\/his.12415","journal-title":"Histopathology"},{"issue":"5","key":"3571_CR24","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1053\/sarh.2002.50012","volume":"32","author":"A Schnabel","year":"2003","unstructured":"Schnabel A, Reuter M, Biederer J, Richter C, Gross WL (2003) Interstitial lung disease in polymyositis and dermatomyositis: clinical course and response to treatment. Semin Arthritis Rheum 32(5):273\u2013284. doi: 10.1053\/sarh.2002.50012","journal-title":"Semin Arthritis Rheum"},{"issue":"1","key":"3571_CR25","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.nmd.2004.09.006","volume":"15","author":"A Teixeira","year":"2005","unstructured":"Teixeira A, Cherin P, Demoule A, Levy-Soussan M, Straus C, Verin E et al (2005) Diaphragmatic dysfunction in patients with idiopathic inflammatory myopathies. Neuromuscul Disord: NMD 15(1):32\u201339. doi: 10.1016\/j.nmd.2004.09.006","journal-title":"Neuromuscul Disord: NMD"},{"issue":"6","key":"3571_CR26","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1038\/nrneurol.2011.63","volume":"7","author":"AL Mammen","year":"2011","unstructured":"Mammen AL (2011) Autoimmune myopathies: autoantibodies, phenotypes and pathogenesis. Nat Rev Neurol 7(6):343\u2013354. doi: 10.1038\/nrneurol.2011.63","journal-title":"Nat Rev Neurol"},{"key":"3571_CR27","doi-asserted-by":"publisher","first-page":"CD003643","DOI":"10.1002\/14651858.CD003643.pub4","volume":"8","author":"PA Gordon","year":"2012","unstructured":"Gordon PA, Winer JB, Hoogendijk JE, Choy EH (2012) Immunosuppressant and immunomodulatory treatment for dermatomyositis and polymyositis. Cochrane Database Syst Rev 8:CD003643. doi: 10.1002\/14651858.CD003643.pub4","journal-title":"Cochrane Database Syst Rev"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-016-3571-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00296-016-3571-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-016-3571-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,25]],"date-time":"2017-06-25T00:39:31Z","timestamp":1498351171000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00296-016-3571-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10,8]]},"references-count":27,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["3571"],"URL":"https:\/\/doi.org\/10.1007\/s00296-016-3571-7","relation":{},"ISSN":["0172-8172","1437-160X"],"issn-type":[{"value":"0172-8172","type":"print"},{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,10,8]]}}}